Your browser is no longer supported. Please, upgrade your browser.
BNGO [NASD]
Bionano Genomics, Inc.
Index- P/E- EPS (ttm)-0.25 Insider Own2.10% Shs Outstand280.17M Perf Week-12.50%
Market Cap625.24M Forward P/E- EPS next Y-0.28 Insider Trans0.08% Shs Float- Perf Month-39.04%
Income-61.20M PEG- EPS next Q-0.07 Inst Own25.70% Short Float- Perf Quarter-60.66%
Sales15.70M P/S39.82 EPS this Y80.20% Inst Trans0.74% Short Ratio4.38 Perf Half Y-67.21%
Book/sh1.22 P/B1.66 EPS next Y-13.60% ROA-21.10% Target Price11.38 Perf Year-81.61%
Cash/sh1.06 P/C1.92 EPS next 5Y- ROE-22.60% 52W Range1.81 - 15.69 Perf YTD-32.11%
Dividend- P/FCF- EPS past 5Y- ROI-75.10% 52W High-86.93% Beta1.90
Dividend %- Quick Ratio18.80 Sales past 5Y- Gross Margin30.70% 52W Low13.25% ATR0.23
Employees147 Current Ratio19.30 Sales Q/Q113.60% Oper. Margin- RSI (14)21.96 Volatility10.09% 9.05%
OptionableYes Debt/Eq0.00 EPS Q/Q8.80% Profit Margin- Rel Volume1.05 Prev Close2.03
ShortableYes LT Debt/Eq0.00 EarningsNov 04 AMC Payout- Avg Volume9.25M Price2.05
Recom1.20 SMA20-21.65% SMA50-37.79% SMA200-61.19% Volume1,428,138 Change0.98%
Jun-16-21Initiated BTIG Research Buy $10
Sep-24-20Initiated Ladenburg Thalmann Buy $1.25
Apr-08-20Initiated Oppenheimer Outperform $1.50
Jan-26-22 08:00AM  
Jan-20-22 08:00AM  
Jan-19-22 10:51PM  
09:36PM  
08:00AM  
Jan-13-22 09:40PM  
06:18PM  
Jan-12-22 04:30PM  
12:15PM  
08:00AM  
Jan-11-22 05:11PM  
Jan-10-22 07:48PM  
06:26PM  
08:00AM  
Jan-07-22 08:00AM  
Jan-03-22 03:33PM  
Dec-29-21 08:00AM  
Dec-28-21 03:42PM  
Dec-27-21 06:00AM  
Dec-23-21 08:00AM  
Dec-22-21 08:05PM  
Dec-16-21 08:00AM  
Dec-14-21 10:35AM  
Dec-10-21 10:34AM  
08:42AM  
Dec-09-21 08:00AM  
Dec-08-21 08:00AM  
Dec-03-21 03:18PM  
Dec-01-21 06:00AM  
Nov-29-21 10:00AM  
08:00AM  
Nov-23-21 05:21PM  
Nov-22-21 08:00AM  
Nov-19-21 02:54PM  
Nov-15-21 08:00AM  
Nov-06-21 01:31AM  
Nov-05-21 05:47AM  
Nov-04-21 08:56PM  
04:05PM  
08:00AM  
Nov-03-21 08:00AM  
Nov-02-21 04:30PM  
Nov-01-21 10:00AM  
Oct-28-21 04:30PM  
02:26PM  
Oct-20-21 08:00AM  
Oct-15-21 08:00AM  
Oct-14-21 12:00PM  
08:00AM  
Oct-13-21 02:32AM  
Oct-12-21 07:45AM  
07:35AM  
Oct-07-21 03:55PM  
Oct-06-21 08:00AM  
Sep-29-21 08:00AM  
Sep-16-21 08:00AM  
05:51AM  
Sep-07-21 08:00AM  
Aug-26-21 08:00AM  
Aug-19-21 09:49AM  
Aug-09-21 10:23AM  
Aug-05-21 04:01AM  
Aug-04-21 06:15PM  
04:05PM  
Jul-29-21 12:51PM  
Jul-28-21 04:30PM  
Jul-27-21 08:00AM  
Jul-26-21 05:50PM  
Jul-23-21 04:56PM  
Jul-19-21 08:00AM  
Jul-16-21 08:07AM  
07:01AM  
Jul-14-21 08:00AM  
Jul-13-21 08:00AM  
Jul-09-21 11:44AM  
Jul-07-21 11:00AM  
08:52AM  
06:06AM  
Jul-06-21 08:00AM  
Jul-02-21 05:50PM  
08:00AM  
Jul-01-21 04:05PM  
Jun-28-21 08:00AM  
Jun-25-21 11:13AM  
Jun-24-21 05:50PM  
05:19AM  
Jun-23-21 08:27AM  
Jun-22-21 09:46AM  
Jun-16-21 01:25PM  
Jun-14-21 08:00AM  
06:15AM  
04:34AM  
Jun-08-21 07:18AM  
Jun-07-21 05:07PM  
08:00AM  
Jun-04-21 05:52AM  
May-29-21 07:07AM  
May-28-21 11:57AM  
May-19-21 04:05PM  
May-18-21 01:28PM  
Bionano Genomics, Inc., a genome analysis company, provides tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. Its Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables scientists and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. The company also provides diagnostic testing for those with autism spectrum disorder and other neurodevelopmental disabilities. In addition, it offers an agnostic cross-platform data interpretation and clinical reporting software that integrates next-generation sequencing and microarray data, and provides visualization of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome for a fully integrated analysis in one view. The company was founded in 2006 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holmlin R. ErikPresident and CEONov 29Buy3.995,02520,0375,025Dec 01 06:00 AM
Stewart Christopher P.Chief Financial OfficerNov 19Option Exercise0.5622,50012,60055,500Nov 23 06:00 AM
Stewart Christopher P.Chief Financial OfficerMay 26Option Exercise0.5625,00014,00033,000May 27 04:36 PM